Recurrent Respiratory Papillomatosis
Symptoms, Doctors, Treatments, Advances & More

Recurrent Respiratory Papillomatosis Overview

Save information for later
Sign Up

Learn About Recurrent Respiratory Papillomatosis

What is the definition of Recurrent Respiratory Papillomatosis?
Recurrent respiratory papillomatosis (RRP) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). There are two types, a juvenile-onset form and an adult-onset form. The tumors can cause a hoarse voice, chronic cough, and difficulty breathing. They may vary in size and grow very quickly, and may grow back even when removed. These tumors rarely become cancerous, but can cause long-term airway and voice complications. RRP is caused by two types of human papillomavirus (HPV), called HPV 6 and HPV 11. It is transmitted from an infected mother to her baby through the placenta or through the birth canal. HPV can also be transmitted from one adult to another through oral sex. The HPV vaccine can help prevent infection.
What are the alternative names for Recurrent Respiratory Papillomatosis?
  • Recurrent respiratory papillomatosis
  • AORRP (type)
  • Adult-onset recurrent respiratory papillomatosis (type)
  • JORRP (type)
  • Juvenile laryngeal papilloma
  • Juvenile-onset recurrent respiratory papillomatosis (type)
  • Laryngeal papilloma, recurrent
  • RRP
  • Respiratory papillomatosis, recurrent
Who are the top Recurrent Respiratory Papillomatosis Local Doctors?
Elite in Recurrent Respiratory Papillomatosis
Dr. Clint T. Allen
Otolaryngology
Elite in Recurrent Respiratory Papillomatosis
Dr. Clint T. Allen
Otolaryngology
Referral may be required

Johns Hopkins Neurosurgery Otolaryngology

9000 Rockville Pike, Suite 4920, Building 7N240, Suite 4920, Building 7N240, 
Bethesda, MD 
240-858-7773
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Clint Allen is an Otolaryngologist practicing medicine in Bethesda, Maryland. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Recurrent Respiratory Papillomatosis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Recurrent Respiratory Papillomatosis, Head and Neck Squamous Cell Carcinoma (HNSCC), Hearing Loss, Human Papillomavirus Infection, and Endoscopy. Dr. Allen is board certified in Head And Neck Surgery.

Elite in Recurrent Respiratory Papillomatosis
Dr. Adam Klein
Otolaryngology
Elite in Recurrent Respiratory Papillomatosis
Dr. Adam Klein
Otolaryngology
Referral may be required

Emory Clinic Urology At Midtown

550 Peachtree St NE Fl 9, 
Atlanta, GA 
404-778-3381
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Adam Klein is an Otolaryngologist practicing medicine in Atlanta, Georgia. Dr. Klein is rated as an Elite provider by MediFind in the treatment of Recurrent Respiratory Papillomatosis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Laryngitis, Laryngectomy, and Tissue Biopsy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Recurrent Respiratory Papillomatosis
Dr. Sara Pai
General Surgery
Elite in Recurrent Respiratory Papillomatosis
Dr. Sara Pai
General Surgery
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
617-724-4000
Languages Spoken:
English
See accepted insurances

Sara Pai is a General Surgeon practicing medicine in Boston, Massachusetts. Dr. Pai is rated as an Elite provider by MediFind in the treatment of Recurrent Respiratory Papillomatosis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Recurrent Respiratory Papillomatosis, Head and Neck Squamous Cell Carcinoma (HNSCC), Human Papillomavirus Infection, Adenoid Cystic Carcinoma, and Thyroidectomy.

View All Doctors
What are the latest Recurrent Respiratory Papillomatosis Clinical Trials?
A Pilot Study of Lenvatinib in Combination With Pembrolizumab in HPV-associated Recurrent Respiratory Papillomatosis Patients
A Pilot Study of Lenvatinib in Combination With Pembrolizumab in HPV-associated Recurrent Respiratory Papillomatosis Patients
Who is this study for: Patients with Recurrent Respiratory Papillomatosis
Enrollment Status: Recruiting
Publish Date: April 16, 2026
Intervention Type: Drug
Study Drugs: Lenvatinib, Pembrolizumab
Study Phase: Early Phase 1

Summary: This research study is studying Lenvatinib in combination with Pembrolizumab in people with human papillomavirus (HPV)-associated recurrent respiratory papillomatosis (RRP). The names of the study drugs involved in this study are: * Pembrolizumab * Lenvatinib

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1 Study Of The Safety And Immunogenicity Of Peptide-loaded Autologous Dendritic Cell Vaccination In Recurrent Respiratory Papillomatosis (RRP) Patients
A Phase 1 Study Of The Safety And Immunogenicity Of Peptide-loaded Autologous Dendritic Cell Vaccination In Recurrent Respiratory Papillomatosis (RRP) Patients
Enrollment Status: Recruiting
Publish Date: April 03, 2026
Intervention Type: Biological
Study Phase: Phase 1

Summary: The purpose of this study is to evaluate the safety and immunogenicity of autologous DC vaccine in recurrent respiratory papillomatosis patients

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center